Penumbra, Inc.
PEN
320.77−0.95 (−0.30%)Nov 12, 7:00 PM ET
Key stats
- Open
- 322.78
- Day high
- 322.78
- Day low
- 320.25
- Previous close
- 321.72
- Volume
- 214.3K
- VWAP
- 320.84
- 52-week high
- 362.41
- 52-week low
- 274.20
- Market cap
- 12.68B
- Shares out
- 39.41M
- Employees
- 4,700
- Listed
- 2015
About Penumbra, Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · ALAMEDA, CA · penumbrainc.com
Options · expiring Nov 20
Nov 12, 3:20 PM ET- Call open interest
- 108
- Put open interest
- 558
- Put/call
- 5.17
- At-the-money IV
- 23.6%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 380 call | 7.00 | Aug 14, 9:32 AM | 17 | 19 | 81.9% |
| 350 put | 86.80 | Oct 8, 10:20 AM | 9 | 1 | — |
| 330 put | 67.00 | Oct 8, 10:19 AM | 8 | 19 | — |
| 330 call | 0.15 | Nov 11, 2:33 PM | 6 | 21 | 12.5% |
| 310 call | 13.80 | Sep 8, 2:33 PM | 5 | 7 | 0.1% |
| 260 put | 0.40 | Nov 12, 2:52 PM | 3 | 27 | 87.6% |
Quarterly results
Massive · Oct 29, 2026| Q3 2026 to Sep 30, 2026 | Q2 2026 to Jun 30, 2026 | Q1 2026 to Mar 31, 2026 | Q4 2025 to Dec 31, 2025 | |
|---|---|---|---|---|
| Revenue | $410.14M | $390.05M | $374.76M | $385.38M |
| Gross profit | $280.30M | $264.94M | $253.41M | $262.13M |
| Operating income | $50.74M | $41.04M | $38.23M | $59.23M |
| Net income | $42.28M | $34.81M | $32.58M | $47.34M |
| Diluted EPS | 1.07 | 0.88 | 0.82 | 1.20 |
| Operating cash flow | $41.51M | $46.08M | $86.97M | $86.48M |
| Assets | $2.03B | $1.97B | $1.90B | $1.83B |
| Liabilities | $441.59M | $443.96M | $424.63M | $398.92M |
| Equity | $1.58B | $1.53B | $1.47B | $1.43B |
Technicals
Massive · Nov 12, 2026- 50-day average320.15
- 200-day average325.89
- RSI (14 days)49.0
Short interest
Massive · Oct 30, 2026- Oct 30, 20262.40M shares · 5.3 days to cover
- Oct 15, 20262.26M shares · 6.8 days to cover
- Sep 30, 20262.25M shares · 4.8 days to cover
- Sep 15, 20261.81M shares · 7.2 days to cover
Related companies
MassiveNews coverage
No stories about Penumbra, Inc. right now.